CompletedNCT04670016

HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Caregivers

Studying Diffuse intrinsic pontine glioma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Calgary
Principal Investigator
Fiona Schulte, PhD
University of Calgary
Intervention
This study does not include an intervention.(other)
Enrollment
20 enrolled
Eligibility
2-21 years · All sexes
Timeline
2020 – 2023

Study locations (13)

Collaborators

University of Toronto · Université de Montréal · University of Ottawa · Western University, Canada · McMaster University · Alberta Children's Hospital · Stollery Children's Hospital · British Columbia Children's Hospital · CancerCare Manitoba · Children's Hospital of Eastern Ontario · The Hospital for Sick Children · McMaster Children's Hospital · Children's Hospital Medical Center, Cincinnati · St. Justine's Hospital · Montreal Children's Hospital of the MUHC · IWK Health Centre · Janeway Children's Health and Rehabilitation Centre · Princess Margaret Hospital, Canada · London Health Sciences Centre · The Ottawa Hospital · CHU de Quebec-Universite Laval

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04670016 on ClinicalTrials.gov

Other trials for Diffuse intrinsic pontine glioma

Additional recruiting or active studies for the same condition.

See all trials for Diffuse intrinsic pontine glioma →

← Back to all trials